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Abstract
Introduction: With the adoption of routine screening mammography, breast cancers are being diagnosed at earlier stages, 
with DCIS now accouting for 22.5% of all newly diagnosed breast cancers. This has been attributed to both increased breast 
cancer awareness and improvements in breast imaging techniques. How have these changes, including the increased use of 
image-guided sampling techniques, inﬂ  uenced the clinical practice of breast surgery?
Methods: The institutional pathology database was queried for all breast surgeries, including breast reconstruction, performed 
in 1995 and 2005. Cosmetic procedures were excluded. The results were analysed utilizing the Chi-square test.
Results: Surgical indications changed during 10-year study period, with an increase in preoperatively diagnosed cancers 
undergoing deﬁ  nitive surgical management. ADH, and to a lesser extent, ALH, became indications for surgical excision. 
Fewer surgical biopsies were performed for indeterminate abnormalities on breast imaging, due to the introduction of ste-
reotactic large core biopsy. While the rate of benign breast biopsies remained constant, there was a higher percentage of 
precancerous and DCIS cases in 2005. The overall rate of mastectomy decreased from 36.8% in 1995 to 14.5% in 2005. 
With the increase in sentinel node procedures, the rate of ALND dropped from 18.3% to 13.7%. Accompanying the increased 
recognition of early-stage cancers, the rate of positive ALND also decreased, from 43.3% to 25.0%.
Conclusions: While the rate of benign breast biopsies has remained constant over a recent 10-year period, fewer diagnostic 
surgical image-guided biopsies were performed in 2005. A greater percentage of patients with breast cancer or preinvasive 
disease have these diagnoses determined before surgery. More preinvasive and Stage 0 cancers are undergoing surgical 
management. Earlier stage invasive cancers are being detected, reﬂ  ected by the lower incidence of axillary nodal 
metastases.
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Introduction
With the widespread use of breast cancer screening by mammography in the industrialized world, breast 
cancers are being diagnosed at increasingly earlier stages. In national surveys, approximately 75% of 
American women 40 years of age and older report having undergone mammography within the last 
two years (Smigal et al. 2006; Ryerson et al. 2007). Currently ductal carcinoma in situ accounts for 
22.5% of newly diagnosed breast cancers (Smigal et al. 2006), while in 1990, it accounted for only 2% 
of all newly diagnosed breast cancers (Adamovich and Simmons, 2003; Esserman, 2006). The Ameri-
can Cancer Society estimates that approximately 212,920 new cases of invasive breast cancer, and 
61,980 cases of in situ disease would be diagnosed in the United States in the year 2006 (Smigal et al. 
2006).
This shift has additionally been attributed to improvements in breast imaging techniques, including 
the increased use of image-guided sampling techniques, and most recently, the use of magnetic resonance 
imaging (MRI) evaluation of the breast (Goethem et al. 2006).52
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In addition, surgical practice has changed 
dramatically as well over the last decade, particu-
larly with the widespread adoption of the sentinel 
node technique for axillary staging (Kim et al. 
2005), and reﬁ  nements in breast reconstruction 
techniques.
How have these changes inﬂ  uenced the clinical 
practice of breast surgery? We reviewed our insti-
tutional experience over a 10 year interval, a period 
in which both radiologic evaluation and clinical 
management of breast disease has undergone sig-
niﬁ  cant change.
Methods
The institutional pathology database was queried 
for all breast surgeries (including breast reconstruc-
tion) performed in the years 1995 and 2005. Cos-
metic procedures were excluded. The year 1995 
was chosen as it was before sentinel node biopsy 
became the standard of care for axillary staging in 
early-stage breast cancer, while 2005 was the most 
recent year for which we had complete data.
The variables examined included year of surgery, 
patient age, preoperative diagnosis, surgical proce-
dure performed, and pathology results. For patients 
undergoing simultaneous but unrelated procedures, 
each procedure was tabulated separately, and the 
pathology results evaluated separately as well. For 
patients with invasive ductal carcinoma (IDC) with 
a component of DCIS, they were tabulated as IDC. 
Cases of DCIS with microinvasion were included 
in the DCIS group. The results were tabulated on 
an Excel spreadsheet, and analyzed utilizing the 
Chi-square test.
Institutional Review Board approval was 
granted.
Results
Surgical indications
Indications for breast surgery changed signiﬁ  cantly 
over the 10-year study period, with an increased 
incidence of pre-operatively diagnosed cancers 
undergoing deﬁ  nitive surgical management, rising 
from 32.4% in 1995 to 39.8% in 2005. ADH, and 
to a lesser extent, ALH, became indications for 
surgical excision. Fewer surgical biopsies were 
performed for indeterminate abnormalities on 
breast imaging, decreasing from 34.2% to 16.8%. 
The results are summarized in Table 1.
There was no signiﬁ  cant change in the rate of 
biopsies performed for a palpable mass, or in the 
rate of benign biopsies (42.3% vs. 41.1%).
There was no signiﬁ  cant change in the percentage 
of biopsies performed for abnormal or indeterminate 
ﬁ  ndings on ﬁ  ne needle aspiration cytology.
Surgical procedures
The rate of mastectomy dropped, from 36.8% in 
1995 to 14.5% in 2005. Accompanying the increase 
in sentinel node procedures, the rate of axillary 
lymph node dissection (ALND) dropped signiﬁ  -
cantly. In 1995, only 6 of 127 patients (4.8%) were 
evaluated for axillary metastases using the sentinel 
node technique. By 2005, 246 (64%) of 384 
patients were staged solely with sentinel lymph-
adenectomy. Accompanying the increased recogni-
tion of early-stage cancers, the rate of positive 
axillary staging also decreased signiﬁ  cantly, from 
43.3% to 25%. Elderly, frail patients, and those 
with signiﬁ  cant life-threatening co-morbidities, did 
not undergo axillary staging.
In 1995, 60 breast reconstructions were per-
formed. All 20 autologous tissue transfer cases 
were pedicled transverse rectus abdominis myo-
cutaneous (TRAM) ﬂ  aps, and the remaining 40 
patients underwent implant procedures. In 2005, 
35 autologous tissue breast reconstructions were 
performed (31 TRAM ﬂ  aps with microvascular 
reanastomoses and 4 pedicled TRAM ﬂ  aps) and 
80 implant procedures.
Pathology
There was a higher incidence of DCIS cases in 
2005, increasing from 23.4% in 1995 to 32.0%. 
The incidence of lobular carcinoma in situ (LCIS) 
was not signiﬁ  cantly different in the two index 
years, probably due to the fact that in the majority 
of cases, LCIS is still a serendipitous ﬁ  nding, due 
to its occult nature on both clinical and radiologic 
evaluation. The incidence of all other pathologic 
diagnoses was essentially unchanged.
The rate of benign breast biopsies remained con-
stant, with 141 of these lesions being ﬁ  broadenomas in 
1995 (71%), and 256 ﬁ  broadenomas in 2005 (73%).
Radiology
By 2005, digital mammography was replacing 
analog mammography. With increasing frequency, 
Magnetic Resonance Imaging examinations (MRI) 53
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were used for high-risk screening and surgical 
planning, but had not yet been adopted as routine 
studies. The use of image-guided biopsies changed 
over the 10-year period (Table 2), with increases in 
the use of both ultrasound-guided ﬁ  ne needle aspi-
ration (FNA) biopsies and core biopsies. Large-bore 
Mammotome™ biopsies largely supplanted stereo-
tactic ﬁ  ne-needle aspiration biopsy for the evalua-
tion of mammographic abnormalities.
By 2005, the vast majority of core biopsies were 
performed under image-guidance by radiologists. 
The core biopsies performed by the surgeons were 
either ofﬁ  ce procedures for diagnosis of a palpable 
mass, or in women with locally-advanced cancers 
who were candidates for neoadjuvant therapy, to 
obtain biomarkers.
Surgeon-operated intraoperative ultrasound has 
not been routinely used in the institution.
Table 1. Comparison of surgical experience: 1995 and 2005.
Characteristics 1995 (n = 661) 2005 (n = 1005) p-values
Indications for surgery
Cancer 214(32.4%) 394(39.2%) 0.001
Abnormal x-ray 215(32.4%) 169(16.8%) 0.001
Palpable mass 199(30.1%) 342(34.0%) NS
Abnormal FNA 30(4.5%) 61(6.1%) NS
ADH 0(0%) 31(3.1%) 0.001
ALH 0(0%) 8(0.8%) 0.025
Mean age (years) 55 +/− 14 53 +/− 15 NS
Type of surgery Note: 27 patients 
underwent multiple 
procedures
Mastectomy 242(36.6%) 150(14.9%) 0.001
Excisional biopsy 237(35.9%) 191(19.0%) 0.001
Needle-localization biopsy 58(8.7%) 235(23.4%) 0.001
Partial mastectomy 151(22.3%) 424(42.2%) 0.001
Core biopsy by surgeon 23(3.5%) 3(0.3%) 0.001
Axillary staging
Sentinel node* 6(1%) 246(24.5%) 0.001
Axillary dissection** 121(18.3%) 138(13.7%) 0.025
Pathology 
(Included multiple 
diagnoses if signiﬁ  cant)
Benign 280(42.3%) 413(41.1%) NS
ADH/ALH 94(19.2%) 138(13.7%) NS
DCIS 155(23.4%) 322(32.0%) 0.001
LCIS 34(5.1%) 75(7.4%) NS
IDC 130(19.7%) 238(23.7%) NS
ILC 24(3.6%) 43(4.3%) NS
IDLC 3(0.5%) 11(1.1%) NS
# positive/all axillary staging 54/127(43.3%) 96/384(25.0%) 0.001
*Performed as initial diagnostic staging technique.
**Performed for suspected/known axillary metastases, or following positive sentinel node biopsy.54
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Faculty
In 1995, three dedicated surgical oncologists and 
three general surgeons with an interest in breast 
diseases performed all the breast cases. By 2005, 
seven dedicated surgical oncologists and one gen-
eral surgeon managed the breast surgical cases. 
The volume increase from 1995 to 2005 was due 
to the expansion of the Breast Service. The case 
mix remained similar in terms of the percent-
age of benign disease. The distribution of cancer 
cases changes however, with an increase in the 
percentage of early stage breast cancers (i.e. DCIS 
and node-negative invasive cancers). In both years 
the surgical philosophy was internally consistent, 
including the adoption of sentinel node techniques, 
the role of re-excision following breast-conserving 
surgery, the use of skin-sparing mastectomy, and 
the reluctance to perform nipple/areolar-sparing 
mastectomy. In 2005, the use of preoperative MRI 
varied among the surgical oncologists, particularly 
as MRI-guided core biopsies and preoperative 
needle-localization techniques were not available 
within the institution at that time.
In 2003, the Pathology Department created a 
Division of Breast Pathology with a core group of 
dedicated breast pathologists. Throughout the 
study period, there has been a dedicated Division 
of Breast Imaging, staffed only by dedicated mam-
mographers.
Discussion
With increased awareness and availability of rou-
tine breast cancer screening, breast cancers are 
being diagnosed at earlier stages. Currently, over 
70% of all newly diagnosed breast cancers in the 
United States are Stages 0–2 (van de Vijver, 2005; 
Smigal et al. 2006).
Accompanying this are major technologic 
changes in breast imaging. Digital mammography 
is quickly becoming the standard of care, especially 
in the evaluation of premenopausal women (Pisano 
et al. 2005). When compared to ﬁ  lm mammography, 
digital mammography has been found to be more 
accurate in women under the age of 50 years, in 
women with radiologically dense breasts, and in 
pre/perimenopausal women.
The widespread adoption of large-bore needle 
image-guided biopsy techniques has had a major 
impact on how breast cancers are diagnosed. 
Rather than undergoing an initial diagnostic surgi-
cal procedure, increasingly patients go to the 
operating room with a histologic diagnosis of a 
high-risk or malignant lesion (Liberman, 1999; 
Crowe et al. 2002). Crowe et al. (10) reported on 
the experience at the Cleveland Clinic from 1995 
to 2000. During that time, the percentage of diag-
nostic breast biopsies performed as image-guided 
core biopsies rather than surgical biopsies increased 
from 31% to 68%. A similar change is reﬂ  ected in 
our data (Tables 1&2).
Within the last few years the role of breast MRI 
has become better deﬁ  ned. In particular, it is now 
being used for surgical planning in the setting of 
a known breast cancer, both to evaluate the extent 
of known disease, and for the detection of 
multifocal, multicentric, and contralateral 
malignancies (Goethem et al. 2006) (Lehman et al. 
2007). It appears that tumor diameter measured on 
MRI correlates more closely with the histologic 
measurements, compared to the diameters mea-
sured on mammography and ultrasound. Thus, it 
is being increasingly used in planning for breast-
conserving therapy.
Indications for surgery
Over this ten-year period the indications for breast 
surgery changed, shifting away from diagnostic 
procedures to therapeutic interventions. This is 
reﬂ  ected by the decreased rate of procedures being 
performed for abnormal mammographic ﬁ  ndings, 
from 32.4% in 1995 to 16.8% in 2005, and the 
increase in preoperative diagnoses of breast cancer 
or pre-malignant lesions such as ADH/ALH from 
32.4% in 1995 to 43.1% in 2005.
Table 2. Comparison of NYU Image-Guided Needle Biopsies: 1995 and 2005.
Biopsy method (# of procedures)  1995  2005
Ultrasound-guided FNA and core biopsies  1  851
Mammographic-guided FNA and mammotome biopsies  36  199
Total # of procedures for year  37  105055
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Surgical procedures
From 1995 to 2005, the mastectomy rate in our 
institution decreased by more than 50%. This is 
due to the liberalization of indications for breast 
conserving therapy to include synchronous tumors 
in same quadrant and lobular cancers, the diagnosis 
of earlier stage cancers, as well as growing interest 
in oncoplastic techniques for breast reconstruction 
following partial mastectomy. These new tech-
niques strive to optimize the efﬁ  cacy of breast 
conserving therapy (BCT) with respect to both 
appropriate local control, as well as cosmetic 
results (Masetti et al. 2006). The increase in BCT 
may also be inﬂ  uenced by the use of preoperative 
MRI—perhaps patients (and surgeons) are more 
comfortable with the decision to proceed with 
breast conservation when an MRI has revealed no 
additional suspicious lesions in either breast.
The increase in sentinel node procedures reﬂ  ects 
that this technique has supplanted the diagnostic 
axillary dissection for routine staging of the axilla 
in early stage breast cancer.
Pathology
Interestingly, the rate of benign biopsies was 
similar in both years. The preoperative evaluation, 
and indications for surgical removal of presumed 
benign lesions in young women, did not change 
appreciably during the study period, and this may 
explain the constant rate of benign biopsy.
When considering the ADH/ALH group, the 
ﬁ  nal surgical pathology results maybe somewhat 
misleading for this group. With the increase in 
image-guided diagnostic core biopsies, we are 
seeing more cases of minimal volume disease in 
which all involved tissue has been removed by the 
large bore vacuum-assisted biopsies, with no 
residual atypia on the subsequent surgical excision. 
This may explain the decrease in rate of ADH/ALH 
in surgical specimens in 2005 (personal commu-
nication, Baljit Singh).
Conclusions
The surgical management of breast disease has 
changed signiﬁ  cantly in our institution during the 
last decade, reﬂ  ecting the widespread reﬁ  nements 
in breast cancer diagnosis and management. The 
management of breast disease has shifted from 
generalists to dedicated surgical oncologists and 
breast pathologists.
While the rate of benign breast biopsies has 
remained constant, more pre-invasive lesions and 
Stage 0 cancers are undergoing surgical manage-
ment. A greater percentage of patients with breast 
disease have their diagnoses determined before 
surgery. Earlier stage invasive cancers are being 
detected, reﬂ  ected by the lower incidence of axil-
lary nodal metastases. Sentinel node biopsy has 
supplanted diagnostic axillary dissection Corre-
spondingly there has been a greater shift towards 
breast conserving therapy.
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